butyric acid has been researched along with B16 Melanoma in 11 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The morphology and ultrastructure of B16 melanoma cells was examined after treatment of the cells with the chemical inducers of differentiation dimethylsulfoxide (DMSO), butyric acid, and dimethylthiourea (DMTU)." | 7.67 | Chemical inducers of differentiation, dimethylsulfoxide, butyric acid, and dimethylthiourea, induce selective ultrastructural patterns in B16 melanoma cells. ( Fuchs, A; Malik, H; Malik, Z; Nordenberg, J; Novogrodsky, A, 1987) |
| "The purpose is to evaluate the CD44-mediated cellular targeting of HA-But, a hyaluronic acid esterified with butyric acid (But) residues, to hepatocellular carcinoma cell lines in vitro and to hepatic tumor metastases in vivo." | 3.72 | Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. ( Bello, M; Cantoni, S; Coradini, D; Mazzi, U; Pellizzaro, C; Perbellini, A; Rossin, R; Sava, G; Scarlata, I; Speranza, A; Turrin, C; Zorzet, S, 2004) |
| "The morphology and ultrastructure of B16 melanoma cells was examined after treatment of the cells with the chemical inducers of differentiation dimethylsulfoxide (DMSO), butyric acid, and dimethylthiourea (DMTU)." | 3.67 | Chemical inducers of differentiation, dimethylsulfoxide, butyric acid, and dimethylthiourea, induce selective ultrastructural patterns in B16 melanoma cells. ( Fuchs, A; Malik, H; Malik, Z; Nordenberg, J; Novogrodsky, A, 1987) |
| "Butyric acid has been known to inhibit growth and to induce differentiation of a variety of tumor cells." | 1.31 | Antitumor activity of tributyrin in murine melanoma model. ( Basak, G; Czajka, A; Giermasz, A; Hoser, G; Jakóbisiak, M; Jalili, A; Lewandowski, S; Makowski, M; Marczak, M; Młynarczuk, I; Nowis, D; Stok osa, T, 2001) |
| "L-ethionine was less effective than sodium butyrate or dimethyl sulfoxide in inhibiting expression of the B8G3 melanosomal antigen, as determined by Western blotting." | 1.28 | Alteration of melanoma melanogenesis by phenotypic modifiers. ( Horikoshi, T; Ito, S; Parsons, PG; Takahashi, H; Wakamatsu, K, 1992) |
| "Butyric acid treatment significantly increased total actin, defined as diffuse actin, plus filamentous subgroup actins 1-4." | 1.28 | A quantitative assessment of F-actin content and distribution in untreated and butyric acid treated murine melanoma B16a tumour cells: a fluorescence image analysis study. ( McGarvey, T; Persky, B, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nudelman, A | 1 |
| Ruse, M | 1 |
| Aviram, A | 1 |
| Rabizadeh, E | 1 |
| Shaklai, M | 1 |
| Zimrah, Y | 1 |
| Rephaeli, A | 1 |
| Candan, G | 1 |
| Michiue, H | 1 |
| Ishikawa, S | 1 |
| Fujimura, A | 1 |
| Hayashi, K | 1 |
| Uneda, A | 1 |
| Mori, A | 1 |
| Ohmori, I | 1 |
| Nishiki, T | 1 |
| Matsui, H | 1 |
| Tomizawa, K | 1 |
| Coradini, D | 1 |
| Zorzet, S | 1 |
| Rossin, R | 1 |
| Scarlata, I | 1 |
| Pellizzaro, C | 1 |
| Turrin, C | 1 |
| Bello, M | 1 |
| Cantoni, S | 1 |
| Speranza, A | 1 |
| Sava, G | 1 |
| Mazzi, U | 1 |
| Perbellini, A | 1 |
| Zhai, Y | 1 |
| Yang, JC | 1 |
| Kawakami, Y | 1 |
| Spiess, P | 1 |
| Wadsworth, SC | 1 |
| Cardoza, LM | 1 |
| Couture, LA | 1 |
| Smith, AE | 1 |
| Rosenberg, SA | 1 |
| Komatsu, Y | 1 |
| Hayashi, H | 1 |
| Giermasz, A | 1 |
| Nowis, D | 1 |
| Jalili, A | 1 |
| Basak, G | 1 |
| Marczak, M | 1 |
| Makowski, M | 1 |
| Czajka, A | 1 |
| Młynarczuk, I | 1 |
| Hoser, G | 1 |
| Stok osa, T | 1 |
| Lewandowski, S | 1 |
| Jakóbisiak, M | 1 |
| Takahashi, H | 1 |
| Horikoshi, T | 1 |
| Wakamatsu, K | 1 |
| Ito, S | 1 |
| Parsons, PG | 1 |
| Orlow, SJ | 1 |
| Chakraborty, AK | 1 |
| Boissy, RE | 1 |
| Pawelek, JM | 1 |
| Persky, B | 1 |
| McGarvey, T | 1 |
| Prasad, KN | 1 |
| Cohrs, RJ | 1 |
| Sharma, OK | 1 |
| Malik, H | 1 |
| Nordenberg, J | 1 |
| Novogrodsky, A | 1 |
| Fuchs, A | 1 |
| Malik, Z | 1 |
11 other studies available for butyric acid and B16 Melanoma
| Article | Year |
|---|---|
Novel anticancer prodrugs of butyric acid. 2.
Topics: Animals; Antineoplastic Agents; Butyrates; Cell Differentiation; Cell Division; Female; Humans; Leuk | 1992 |
Combining poly-arginine with the hydrophobic counter-anion 4-(1-pyrenyl)-butyric acid for protein transduction in transdermal delivery.
Topics: Administration, Cutaneous; Animals; Anions; Butyric Acid; Cell Survival; Drug Delivery Systems; Gree | 2012 |
Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But.
Topics: Animals; Butyric Acid; Carcinoma, Hepatocellular; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Surv | 2004 |
Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
Topics: Adenoviridae; Adenovirus E3 Proteins; Animals; Antigens, Neoplasm; Butyrates; Butyric Acid; Cell Lin | 1996 |
Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells.
Topics: Animals; Bacillus megaterium; Butyrates; Butyric Acid; Enzyme Inhibitors; Hemiterpenes; Histocompati | 1998 |
Antitumor activity of tributyrin in murine melanoma model.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Butyric Acid; Cell Cycle; Cell Division; Dose-Res | 2001 |
Alteration of melanoma melanogenesis by phenotypic modifiers.
Topics: Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Division; Dimethyl Sulfoxide; Ethionine; gamma-G | 1992 |
Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers.
Topics: 1-Methyl-3-isobutylxanthine; Acetamides; Animals; Butyrates; Butyric Acid; Cell Transformation, Neop | 1990 |
A quantitative assessment of F-actin content and distribution in untreated and butyric acid treated murine melanoma B16a tumour cells: a fluorescence image analysis study.
Topics: Actins; Animals; Butyrates; Butyric Acid; Fluorescence; Image Processing, Computer-Assisted; Melanom | 1990 |
Decreased expressions of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Butyrates; Butyric Acid; Cell Differentiati | 1990 |
Chemical inducers of differentiation, dimethylsulfoxide, butyric acid, and dimethylthiourea, induce selective ultrastructural patterns in B16 melanoma cells.
Topics: Animals; Butyrates; Butyric Acid; Cell Differentiation; Cytoplasmic Granules; Dimethyl Sulfoxide; Me | 1987 |